Monalisa Ultra™ Dermal Filler
High-Purity Hyaluronic Acid 23mg/ml
Monalisa Ultra™ is a clinically-engineered HA filler containing 23mg/ml of high-purity hyaluronic acid with uniform particles. FDA-cleared formula demonstrates 94% patient satisfaction in volume restoration (2023 clinical trial). Certified under KGMP and ISO 13485 standards with endotoxin levels below 0.05 EU/ml and BDDE-free formulation for premium safety.
- Premium Safety: Endotoxin levels below 0.05 EU/ml with BDDE-free formulation
- Long-Lasting Results: 12-18 month duration with optimal viscoelasticity (G’ modulus: 350 Pa)
- Advanced Technology: Monophasic HA matrix with 86% cross-linking rate
- Natural Enhancement: 94% patient satisfaction in clinical volume restoration trials
High-purity hyaluronic acid
Genoss Cross-Linking Technology with monophasic HA matrix
Prefilled syringe with needles included
Stable at recommended temperature range
KGMP and ISO 13485 certified
Contraindications: Patients with autoimmune disorders or active skin infections
Adverse Effects: May include swelling, redness, or tenderness at injection site
Professional Note: Individual results may vary based on skin type and technique
Warning: Not for self-administration
• Monalisa Ultra requires prescription and professional administration
• Always follow aseptic techniques during administration
• Review full IFU prior to application
• Manufacturer not liable for off-label use
• Monitor for hypersensitivity reactions during initial administration
We are an authorized wholesale distributor of medical aesthetic products. This product information is provided for professional healthcare providers only. We do not sell directly to end-users. All products must be prescribed and administered by qualified medical professionals in accordance with local regulations. Product specifications may vary by batch – please confirm actual parameters before use. Product images may differ from actual packaging.
English 
Chinese
Reviews
There are no reviews yet.